BSECompany Update10 Aug 2026 · 10 Aug 2026, 03:07 pm

Newspaper Publication

Akums Drugs and Pharmaceuticals Ltd · 544222

✦ AI SummaryResults

Akums Drugs and Pharmaceuticals Ltd has published un-audited financial results for the quarter ended June 30, 2026, as approved by the Board of Directors on August 08, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Akums Drugs and Pharmaceuticals Ltd - 544222 - Newspaper Publication

Attachments (1)

📄

98f4b10c-4cdb-4669-b39e-0b5a390d2439.pdf

pdf

Download →
View document text
Ref: Akums/Exchange/2026-27/41 August 10, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Newspaper Publication Respected Sir/Ma’am, Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the newspaper advertisements published on August 09, 2026 in the following newspapers: 1. Financial Express (English – New Delhi Edition) 2. Jansatta (Hindi – New Delhi Edition) The advertisements contain a Quick Response (QR) Code enabling direct access to the un- audited (Standalone & Consolidated) Financial Results of Akums Drugs and Pharmaceuticals Limited (“the Company”) for the quarter ended June 30, 2026 as approved by the Board of Directors at its meeting held on August 08, 2026. A copy of this disclosure is being updated on the website of the Company at www.akums.in This is for your kind information and records. Thanking You Yours Faithfully For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer Encl.: As Above